Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 5, 1996, Pages 534-539

  Schmidt, Marie Luise ^a   Huang, Richard ^a   Martin, John A ^a   Henley, Jewel ^a   Mawal Dewan, Madhumalti ^a   Hurtig, Howard I ^b   Lee, Virginia M Y ^a   Trojanowski, John Q ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b GRADUATE HOSPITAL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alzheimer's disease; Neurofibrillary lesions; Progressive supranuclear palsy; tau

Indexed keywords

EPITOPE; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ANTIGEN DETECTION; ANTIGEN RECOGNITION; ARTICLE; BRAIN STEM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

EID: 0029971280     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199605000-00006     Document Type: Article

References (45)

1. Goedert M, Trojanowski JQ, Lee VM-Y. The neurofibrillary pathology of alzheimer's disease. In: Prusiner SB, Rosenberg, RN, Di Mauro, S, and Barchi, RL eds. The molecular and genetic basis of neurological disease. Boston, MA: Butterworth Heineman Press, 1996, in press
2. Kidd M. Alzheimer's disease - an electron microscopical study. Brain 1964;87:307-20
3. Tellez-Nagel I, Wisniewski HM. Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Arch Neurol 1973;29:324-27
4. Roy S, Datta CK, Hirano A, Ghatak NR, Zimmermann HM. Electron microscopic study of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome. Acta Neuropathol 1974;28:175-79
5. Tomonaga M. Ultrastructure of neurofibrillary tangles in progressive supranuclear palsy. Acta Neuropathol 1977;37:177-81
6. Ghatak NR, Nochlin D, Hadfield MG. Neurofibrillary pathology in progressive supranuclear palsy. Acta Neuropathol 1980;52:73-76
7. Takauchi S, Mizuhara T, Miyoshi K. Unusual paired helical filaments in progressive supranuclear palsy. Acta Neuropathol 1983;59:225-28
8. Lee VM-Y, Balin BJ, Otvos L, Jr., Trojanowski JQ. A68: A major subunit of Alzheimer disease paired helical filaments and derivatized forms of normal tau. Science 1991;251:675-78
9. Yen S-H, Horoupian DS, Terry RD. Immunocytochemical comparison of neurofibrillary tangles in senile dementia of Alzheimer type, progressive supranuclear palsy, and postencephalitic Parkinsonism. Ann Neurol 1983;13:172-75
10. Bancher C, Lassmann H. Budka H, et al. Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: Antigenic similarities and differences Microtubule-associated protein tau antigenicity is prominent in all types of tangles. Acta Neuropathol 1987;74.39-46
11. Vermersch P, Robitaille Y, Bernier L, Wattez A, Gauvreau D, Delacourte A. Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: Evidence for general cortical involvement. Acta Neuropathol 1994;87:572-77
12. Flament S, Delacourte A, Verny P, Hauw J-J, Javoy-Agid F. Abnormal tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol 1991;81:591-96
13. Schmidt ML, Lee VM-Y, Hurtig H, Trojanowski JQ. Properties of antigenic determinants that distinguish neurofibrillary tangles in progressive supranuclear palsy and Alzheimer's disease. Lab Invest 1988;59:460-66
14. Iwatsubo T, Hasegawa M, Ihara Y. Neuronal and glial tau-positive inclusions in diverse neurologic diseases share common phosphorylation characteristics. Acta Neuropathol 1994;88:129-36
15. Feany MB, Ksiezak-Reding H, Liu WK, Vincent I, Yen S-HC, Dickson DW. Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: Differentiation from progressive supranuclear palsy. Acta Neuropathol 1995;90:37-43
16. Hauw J-J, Daniel SE, Dickson D, et al. Preliminary KINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurol 1994;44:2015-19
17. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985,42:1097-1105
18. Schmidt ML, DiDario AG, Lee VM-Y, Trojanowski JQ. An extensive neocortical network of PHFtau-rich dystrophic neuntes permeates nearly all neuritic and diffuse plaques in the Alzheimer disease brain. FEBS Lett 1994;344:69-73
19. Vickers JC, Delacourte A, Morrison JH. Progressive transformation of the cytoskeleton associated with normal aging and Alzheimer's disease. Brain Res 1992;594:273-78
20. Bramblett GT, Goedert M, Jakes R, Merrick SE, Trojanowski JQ, Lee VM-Y. Abnormal tau phosphorylation at ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 1993;10:1089-99
21. Bramblett GT, Trojanowski JQ, Lee VM-Y. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent τ and accumulations of abnormal Δ-isoforms (A68). Lab Invest 1992;66:212-22
22. Biernat J, Mandelkow E-M, Schroeter C, et al The switch of tau protein to an Alzheimer-like state induces the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J 1992;11:1593-97
23. Goedert M, Jakes R, Crowther RA, et al. The abnormal phosphorylation of tau protein at serine202 in Alzheimer's disease recapitulates phosphorylation during development. Proc Natl Acad Sci USA 1993;90:5066-70
24. Goedert M, Jakes R, Crowther RA, et al. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: Identification of phosphorylation sites in tau protein Biochem J 1994;301:871-77
25. Goedert M, Jakes R, Vanmechelen E. Monoclonal antibody AT8 recognizes tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995,189,167-70
26. Goedert M, Spillantini MG, Cairns NJ, Crowther RA Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms. Neuron 1992;8:159-68
27. Goedert M, Spillantini MG, Jakes R. Localization of the Alz-50 epitope in recombinant human microtubule-associated protein tau. Neurosci Lett 1991;126:149-54
28. PHF proteins display the same biochemical properties as normal τ. J Biol Chem 1992;267:564-69
29. Kosik KS, Orrechio LD, Binder LI, Trojanowski JQ, Lee VM-Y, Lee G. Epitopes that span the tau molecule are shared with paired helical filaments. Neuron 1988;1:817-25
30. Lang E, Szendrei GI, Lee VM-Y, Otvos L, Jr. Immunological and conformational characterization of a phosphorylated immunodominant epitope on the paired helical filaments found in Alzheimer's disease. Biochem Biophys Res Commun 1993;187:783-90
31. Matsuo ES, Shin R-W, Billingsley ML, et al. Biopsy derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 1994; 13: 989-1002
32. Mercken M, Vandermeeren M, Luebke U, et al. Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 1992;84: 265-72
33. Otvos L, Jr, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM-Y. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404 J Neurosci Res 1994;39: 669-73
34. Seubert P, Mawal-Dewan M, Barbour R, et al. Detection of phosphorylated ser262 in fetal tau, adult tau, and paired helical filament tau. J Biol Chem 1995;270:18917-22
35. Trojanowski JQ, Schuck T, Schmidt ML, Lee VM-Y. Distribution of tau proteins in the normal central and peripheral nervous system. J Histochem Cytochem 1989;37:209-15
36. Wolozin BL, Pruchnicki A, Dickson DW, Davies P. A neuronal antigen in the brains of Alzheimer patients. Science 1986;232: 648-51
37. Shaw G, Chau V. Ubiquitin and microtubule-associated protein tau immunoreactivity each define distinct structures with differing distributions and solubility properties in Alzheimer brain. Proc Natl Acad Sci USA 1988;85:2854-58
38. Lee VM-Y, Carden MJ, Schlaepfer WW, Trojanowski JQ. Monoclonal antibodies distinguish several differentially phosphorylated states of the largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats. J Neurosci 1987;7:3474-88
39. Yagishita S, Ito Y, Amano N, Nakano T, Saitoh A. Ultrastructure of neurofibrillary tangles in progressive supranuclear palsy. Acta Neuropathol 1979;48:27-30
40. Montpetit V, Clapin DF, Guberman A. Substructure of 20 nm filaments of progressive supranuclear palsy. Acta Neuropathol 1985;68:311-18
41. Schmidt ML, Lee VM-Y, Trojanowski JQ. Relative abundance of tau and neurofilament epitopes in hippocampal neurofibrillary y tangles. Am J Pathol 1990;136:1069-75
42. Leigh PN, Probst A, Dale GE, et al. New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies. Acta Neuropathol 1989;79:61-72
43. Cruz-Sanchez FF, Rossi ML, Cardozo A, Deacon P, Tolosa E. Clinical and pathological study of two patients with progressive supranuclear palsy and Alzheimer's changes. Antigenic determinants that distinguish cortical and subcortical neurofibrillary tangles. Neurosci Lett 1992;136:43-46
44. Love S, Saitoh T, Quijada S, Cole GM, Terry RD. Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. J Neuropathol Exper Neurol 1988;47:393-405
45. Shin R-W, Kitamoto T, Tateishi J. Modified tau is present in younger nondemented persons: A study of subcortical nucelei in Alzheimer's disease and progressive supranuclear palsy. Acta Neuropathol 1991;81:517-23